Anti-Human TCR Recombinant Antibody (UC3-10A6) (CAT#: TAB-562CT)

Recombinant monoclonal antibody specifically binds to the extracellular constant domain of the TCR α chain. This antibody can be potentially used in treating T-cell malignancies.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Published Data
  • Datasheet
  • MSDS
  • COA
IHC

Figure 1 Vγ4 T cells have a negative impact on skin wound healing.

Figure 1 Vγ4 T cells have a negative impact on skin wound healing.

Age- and sex-matched C57BL/6 wild-type mice were intraperitoneally injected with 200 μg/mouse Vγ4 T-cell depletion (Vγ4D) Ab UC3 on day 3 before wound excision. Full-thickness wounds were then generated using a sterile 6 mm punch tool on day 0. Wound-closure kinetics was measured over time in wound model without contraction.

Li, Y., Wang, Y., Zhou, L., Liu, M., Liang, G., Yan, R., ... & Huang, Y. (2018). Vγ4 T cells inhibit the pro-healing functions of dendritic epidermal T cells to delay skin wound closure through IL-17A. Frontiers in Immunology, 9, 240.

WB

Figure 2 Vγ4 T cells inhibited epidermal IGF-1 production to delay skin wound repair.

Figure 2 Vγ4 T cells inhibited epidermal IGF-1 production to delay skin wound repair.

Full-thickness wounds were generated in Vγ4 T-cell depletion (Vγ4D) and control mice. On day 3, 5, and 7 post-wounding, each group of epidermis tissues at wound margins was collected from at least three mice for further analysis of IGF-1 production by means of WB.

Li, Y., Wang, Y., Zhou, L., Liu, M., Liang, G., Yan, R., ... & Huang, Y. (2018). Vγ4 T cells inhibit the pro-healing functions of dendritic epidermal T cells to delay skin wound closure through IL-17A. Frontiers in Immunology, 9, 240.

IHC

Figure 3 Vγ4 T cells inhibited epidermal IGF-1 production to delay skin wound repair.

Figure 3 Vγ4 T cells inhibited epidermal IGF-1 production to delay skin wound repair.

Full-thickness wounds were generated in Vγ4 T-cell depletion (Vγ4D) and control mice. On day 3, 5, and 7 post-wounding, each group of epidermis tissues at wound margins was collected from at least three mice for further analysis of IGF-1 production by means of IHC.

Li, Y., Wang, Y., Zhou, L., Liu, M., Liang, G., Yan, R., ... & Huang, Y. (2018). Vγ4 T cells inhibit the pro-healing functions of dendritic epidermal T cells to delay skin wound closure through IL-17A. Frontiers in Immunology, 9, 240.

FC

Figure 4 IGF-1 production by dendritic epidermal T cells (DETCs) around wound area was enhanced in Vγ4 T cell depletion mice.

Figure 4 IGF-1 production by dendritic epidermal T cells (DETCs) around wound area was enhanced in Vγ4 T cell depletion mice.

The percentages of Vγ5 T cells in epidermis at wound margin of Vγ4 T-cell depletion (Vγ4D) and control mice were detected by FACS on days 0 after wounding.

Li, Y., Wang, Y., Zhou, L., Liu, M., Liang, G., Yan, R., ... & Huang, Y. (2018). Vγ4 T cells inhibit the pro-healing functions of dendritic epidermal T cells to delay skin wound closure through IL-17A. Frontiers in Immunology, 9, 240.

IF

Figure 5 Age- and sex-matched TCRδ-GFP mice were intraperitoneally injected with Vγ4D Ab UC3 or isotype control Ab (Control) on day −3.

Figure 5 Age- and sex-matched TCRδ-GFP mice were intraperitoneally injected with Vγ4D Ab UC3 or isotype control Ab (Control) on day −3.

The morphology of DETCs around the wounds in Vγ4D and wild-type (WT) control mice were analyzed by confocal microscopy.

Li, Y., Wang, Y., Zhou, L., Liu, M., Liang, G., Yan, R., ... & Huang, Y. (2018). Vγ4 T cells inhibit the pro-healing functions of dendritic epidermal T cells to delay skin wound closure through IL-17A. Frontiers in Immunology, 9, 240.


Specifications

  • Host Species
  • Humanized
  • Type
  • Humanized antibody
  • Specificity
  • Human
  • Species Reactivity
  • Human
  • Clone
  • UC3-10A6
  • Applications
  • IHC, WB, FC, IF
  • Related Disease
  • Autoimmune Disease, T-cell malignancies

Applications

  • Application Notes
  • This antibody has been reported for use in Immunohistochemistry, Western Blot, Flow Cytometry and Immunofluorescence.

Target

  • Alternative Names
  • TCR; T cell receptor; TCRA; TCRB

Related Resources

  • Related Diseases
  • Related Signaling Pathways

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone UC3-10A6"

See other products for "TCR"

Select a product category from the dropdown menu below to view related products.
Please select product type
ScFv Antibody Products IgG Antibody Products Fab Antibody Products Mouse Antibody Products Humanized Antibody Products ADCC Enhanced Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-562CT. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare